CAGGIANO, ANTHONY,GANGULY, ANINDITA,IACI, JENNIFER,PARRY, TOM
申请号：
EP09813336
公开号：
EP2320933A4
申请日:
2009.07.17
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
